HIKAL
Back to Balance Sheet
|
HIKAL Last 5 Year Total Debt History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Debt | ₹681 Cr | ₹762 Cr | ₹815 Cr | ₹748 Cr | ₹674 Cr |
What is the latest Total Debt ratio of HIKAL ?
| Year | Total Debt |
|---|---|
| Mar2026 | ₹681 Cr |
| Mar2025 | ₹762 Cr |
| Mar2024 | ₹815 Cr |
| Mar2023 | ₹748 Cr |
| Mar2022 | ₹674 Cr |
How is Total Debt of HIKAL Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2026 | ₹681 Cr | -10.69 | |
| Mar2025 | ₹762 Cr | -6.47 | |
| Mar2024 | ₹815 Cr | 8.94 | |
| Mar2023 | ₹748 Cr | 10.90 | |
| Mar2022 | ₹674 Cr | - | |
Compare Total Debt of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,494.4 Cr | -4.1% | -5.6% | -19.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,283.0 Cr | 0.9% | -5% | 3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹251,611.0 Cr | 3.6% | -1.4% | 37.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹175,182.0 Cr | 1.7% | -6.7% | 28% | Stock Analytics | |
| CIPLA | ₹109,063.0 Cr | 2.8% | -3.9% | -17.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,926.0 Cr | 5.4% | 8.7% | 1.6% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -4.1% |
-5.6% |
-19.3% |
| SENSEX | -0.3% |
-1.6% |
-12.3% |
You may also like the below Video Courses